BlackRock Inc. - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 17 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BlackRock Inc. ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$0–6720.0%0.00%–
Q2 2018$0–6720.0%0.00%–
Q1 2018$0–6720.0%0.00%–
Q4 2017$0–6720.0%0.00%–
Q3 2017$0
-100.0%
6720.0%0.00%–
Q2 2017$1,000
-50.0%
6720.0%0.00%–
Q1 2017$2,000–672–0.00%–
 Download
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 276,530$5,0000.00%
IFP Advisors, Inc 95$00.00%
Certified Advisory Corp 20$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders